Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Blood Profile to Predict Recurrence and Response to Systemic Therapy

NCT03267381 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.

NCT NCT03267381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03267381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Blood Profile to Predict Recurrence and Response to Systemic Therapy
Lead sponsor
Vanderbilt-Ingram Cancer Center
Phase
Observational
Overall status
Completed
Start date
October 3, 2017
Completion date
September 27, 2023
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma